Vimarsana
Biggest News Aggregation in the World

Tanner Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tanner Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tanner Pharma Group Today - Breaking & Trending Today

Comprehensive Review Highlights Potential Benefits of Leukine® in Management of Gastrointestinal (GI) Adverse Events Associated with Immune Checkpoint Inhibitors (ICIs) in the Treatment of Cancer - Vimarsana News

Comprehensive Review Highlights Potential Benefits of Leukine® in Management of Gastrointestinal (GI) Adverse Events Associated with Immune Checkpoint Inhibitors (ICIs) in the Treatment of Cancer

Published: April 29, 2024

NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment

Source: thestatehousefile.com
Related Topics:
United StatesDana Farber Cancer InstituteAhmada TarhiniF Stephen Hodi JrH Lee Moffitt Cancer CenterProfessor Of Oncologic SciencesMelanoma CommitteeTanner Pharma GroupPrnewswire Partner Therapeutics IncClinical Translational ResearchNational Cancer InstitutePartner Therapeutics IncOncology At Dana Farber Cancer InstituteResearch InstituteStudy CoCancer Research GroupAmerican Cancer SocietyFront Line TreatmentMelanoma HeadsLast StagesMichael DouganAssociate ProfessorMassachusetts GeneralFront Line MetastaticStudy Chair
Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Vimarsana News

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Published: April 4, 2024

Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®

Source: eagletribune.com
Related Topics:
United StatesRobert MulroyPartner Therapeutics IncDivision Of Pioneering Advanced TherapeuticsNobelpharma CoDevice AgencyInnovation Of Niigata University Medical Dental HospitalJapanese PharmaceuticalsNiigata UniversityTanner Pharma GroupPrnewswire Partner Therapeutics IncTrade Name SargmalinMedical Device AgencySponsor Investigator Koh NakataProject ProfessorPioneering Advanced TherapeuticsMedical InnovationNiigata University Medical DentalWhole Lung LavagePulmonary AlveolarHematopoietic SyndromeAcute Radiation SyndromeSafety InformationBacteriostatic Water
Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Vimarsana News

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Published: April 3, 2024

/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...

Source: prnewswire.com
Related Topics:
United StatesRobert MulroyDevice AgencyInnovation Of Niigata University Medical Dental HospitalJapanese PharmaceuticalsTanner Pharma GroupDivision Of Pioneering Advanced TherapeuticsNobelpharma CoNiigata UniversityPrnewswire Partner Therapeutics IncTrade NameMedical Device AgencySponsor Investigator Koh NakataProject ProfessorPioneering Advanced TherapeuticsMedical InnovationNiigata University Medical DentalWhole Lung LavagePulmonary AlveolarHematopoietic SyndromeAcute Radiation SyndromeSafety InformationBacteriostatic Water
Comprehensive Review Highlights Importance of Leukine® in Combination with Anti-GD2 Immunotherapy for Treatment of High-Risk Pediatric Neuroblastoma - Vimarsana News

Comprehensive Review Highlights Importance of Leukine® in Combination with Anti-GD2 Immunotherapy for Treatment of High-Risk Pediatric Neuroblastoma

Published: January 17, 2024

/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced today the publication of a comprehensive review by Mora et al. in the International Journal of...

Source: prnewswire.com
Related Topics:
United StatesComunidad Autonoma De CatalunaJaume MoraPrnewswire Partner Therapeutics IncTanner Pharma GroupInternational Journal Of CancerInternational JournalScientific DirectorSant JoanBarcelona ChildrenHematopoietic SyndromeAcute Radiation SyndromeSafety InformationBacteriostatic Water
Partner sues NC businessman for $200m in pandemic profits - Vimarsana News

Partner sues NC businessman for $200m in pandemic profits

Published: June 2, 2023

Charlotteobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from charlotteobserver.com Daily Mail and Mail on Sunday newspapers.

Source: charlotteobserver.com
Related Topics:
North CarolinaUnited StatesWake ForestUnited KingdomGreat BritainTanner PharmaBikin MikeAlex ErwinMichael GordonStephen ScaliaFs Medical SuppliesRussell Guerin Melanoma Research FundNc State UniversityTanner Pharma United KingdomLevine Cancer InstituteTanner Pharma GroupUnited Kingdom Department Of HealthAtrium Health Levine Children HospitalUnited Kingdom DepartmentSocial CareCharlotte ObserverNorthern DistrictWestern DistrictCharlotte Country DayAtrium Health